Thus, our results illustrate that USP12, as a convergent regulator downstream of tumour-driven events in NSCLC, plays a role in reprogramming the TME and influences the tumour response to immune checkpoint blockade. The gene discussed is USP12; the disease is non-small cell lung carcinoma.